Login/Sign Up
Supraplase 40 Kit Injection 1's
Supraplase 40 Kit Injection is a clot-busting drug indicated to reduce the risk of death in people who have had a severe type of heart attack known as acute ST-elevation myocardial infarction (STEMI). It contains Tenecteplase, which helps to dissolve unwanted blood clots in the heart's blood vessels. Thus, it helps to prevent damage caused by heart attacks and has been shown to save lives.
₹45050.4*
MRP ₹54939.5
18% off
₹46698.5*
MRP ₹54939.5
15% CB
₹8241 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Supraplase 40 Kit Injection belongs to the class of drugs called thrombolytics (clot-busting drugs) indicated to reduce the risk of death in people who have had a serious type of heart attack known as acute ST-elevation myocardial infarction (STEMI). Heart attack refers to blocked blood flow to the heart due to blockage of arteries. STEMI is a type of serious heart attack that mainly affects the lower chambers of the heart.
Supraplase 40 Kit Injection contains Tenecteplase, a clot-busting drug that helps to dissolve unwanted blood clots in the blood vessels of the heart. Thus, it helps to prevent damage caused by heart attack.
Supraplase 40 Kit Injection will be administered by a healthcare professional; do not self-administer. Supraplase 40 Kit Injection may cause common side effects such as bleeding, nosebleeds, bruising, bleeding at the injection or puncture site, or blood in the urine. If you notice such side effects, please inform your doctor.
If you are allergic to Tenecteplase or any other medicines, please tell your doctor. Supraplase 40 Kit Injection should be used with caution in patients aged over 75 years and who weigh less than 60 kg. Supraplase 40 Kit Injection is not recommended for children below 18 years of age as the safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, please inform your doctor before receiving Supraplase 40 Kit Injection. If you have had a recent major surgery or trauma, inform your doctor.
Supraplase 40 Kit Injection contains Tenecteplase, a clot-busting drug indicated to reduce the risk of death in people who have had a serious type of heart attack known as acute ST-elevation myocardial infarction (STEMI). It helps to dissolve unwanted blood clots in the blood vessels of the heart. Thus, it helps to prevent damage caused by heart attack and has been shown to save lives.
If you are allergic to Tenecteplase or any other medicines, please tell your doctor. Supraplase 40 Kit Injection should be used with caution in patients aged over 75 years of age and who weigh less than 60 kg. Supraplase 40 Kit Injection is not recommended for children below 18 years of age as the safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, please inform your doctor before receiving Supraplase 40 Kit Injection. If you have had a recent major surgery or trauma, inform your doctor. Supraplase 40 Kit Injection is not recommended if you have been given cardiopulmonary resuscitation (chest compressions) for more than 2 minutes duration in the last two weeks. You are advised to be careful while using sharp objects, cutting nails, or shaving, as Supraplase 40 Kit Injection may increase the risk of bleeding.
Drug-Drug Interaction: Supraplase 40 Kit Injection may interact with blood thinners (ticlopidine, clopidogrel, heparin, vitamin K antagonists).
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: Supraplase 40 Kit Injection is not recommended if you have or had a bleeding disorder or recent history of bleeding, brain tumour, stroke, severe high blood pressure, abnormality of the blood vessels or aneurysm or recent major surgery or trauma to your brain or spine. If you have or had recent major surgery or trauma, high blood pressure, severe liver failure, serious infection or inflammation, bleeding disorder, stroke, heart problems, or recent bleeding in the gastrointestinal or urinary systems, inform your doctor before receiving Supraplase 40 Kit Injection.
Acute myocardial infarction (Heart attack): It refers to blocked blood flow to the heart due to acute blockage of arteries. A blockage can develop due to a buildup of plaque, a substance mostly made of cholesterol, fat, or cellular waste products or due to a sudden blood clot that forms on the blockage. The symptoms include chest pain, shortness of breath, sweating, anxiety, and a fast heart rate. Acute ST-elevation myocardial infarction (STEMI) is a type of serious heart attack that mainly affects the lower chambers of the heart and causes a distinct pattern on ECG (electrocardiogram).
Alcohol
Not applicable
Supraplase 40 Kit Injection is administered to hospitalized patients.
Pregnancy
Consult your doctor
Limited data is available on the effect of Supraplase 40 Kit Injection in pregnant women. If you are pregnant or planning pregnancy, inform your doctor before receiving Supraplase 40 Kit Injection. Your doctor may give this medicine if the benefits outweigh the risks.
Breast Feeding
Consult your doctor
It is unknown whether Tenecteplase is excreted in breast milk. Hence, if you are a nursing mother, inform your doctor before receiving Supraplase 40 Kit Injection. Your doctor may give this medicine if the benefits outweigh the risks.
Driving
Not applicable
Supraplase 40 Kit Injection is administered to hospitalized patients.
Liver
Consult your doctor
The effect of liver impairment on the actions of Supraplase 40 Kit Injection in humans has not been particularly studied. However, if you have severe liver failure, inform your doctor before receiving Supraplase 40 Kit Injection.
Kidney
Consult your doctor
The effect of kidney impairment on the actions of Supraplase 40 Kit Injection in humans has not been particularly studied. However, if you have severe kidney problems, inform your doctor before receiving Supraplase 40 Kit Injection.
Children
Unsafe
Supraplase 40 Kit Injection is not recommended for children below 18 years of age as the safety and effectiveness were not established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes